Omega-3 Fatty Acids (EPA/DHA) के लिए Autoimmune Conditions
B संबंधित साक्ष्य कम से कम एक यादृच्छिक परीक्षण इसका समर्थन करता है, जिसके परिणाम अधिकतर सुसंगत हैं।The VITAL trial showed a 15% reduction in autoimmune disease risk with omega-3 supplementation. Additional clinical trials demonstrate benefits for supporting balanced inflammatory responses in rheumatoid arthritis and inflammatory bowel disease.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'immunecited.com';
const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dautoimmune\u002Dconditions';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
B
निष्कर्ष
The VITAL trial showed a 15% reduction in autoimmune disease risk with omega-3 supplementation. Additional clinical trials demonstrate benefits for supporting balanced inflammatory responses in rheumatoid arthritis and inflammatory bowel disease.
Key Study Findings
Review
Impact of Nutritional Diet Therapy on Rheumatoid Arthritis Disease Activity.
Dose: None
बनाम: None
Outcome: rheumatoid arthritis disease activity modulation through diet
प्रभाव: None
None
जनसंख्या: patients with rheumatoid arthritis
Case Reports
n=1
GPIHBP1 Autoantibody-Related Hypertriglyceridemia in a 12-Year-Old Girl With Systemic Lupus Erythematosus.
Dose: None
बनाम: None
Outcome: GPIHBP1 autoantibody and LPL mass normalization
प्रभाव: None
None
जनसंख्या: 12-year-old girl with SLE and severe hypertriglyceridemia
Review
Epigenetic and Mitochondrial Metabolic Dysfunction in Multiple Sclerosis: A Review of Herbal Drug Approaches and …
Dose: None
बनाम: None
Outcome: Epigenetic and mitochondrial modulation in MS
प्रभाव: None
None
जनसंख्या: Multiple sclerosis patients (review)
Review
The Role of Nutrition in the Development, Management, and Prevention of Rheumatoid Arthritis: A Comprehensive …
Dose: None
बनाम: None
Outcome: RA risk and disease activity
प्रभाव: None
None
जनसंख्या: Patients with rheumatoid arthritis
Review
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives.
Dose: None
बनाम: None
Outcome: None
प्रभाव: None
None
जनसंख्या: None
Systematic Review
Modulating inflammation and oxidative stress in rheumatoid arthritis: a systematic review of nutraceutical interventions.
Dose: None
बनाम: None
Outcome: None
प्रभाव: None
None
जनसंख्या: Systematic review of nutraceuticals in rheumatoid arthritis
Key Statistics
10
अध्ययन
25000
प्रतिभागी
↑
Positive
B
ग्रेड
Referenced Papers
Case reports in …
2026
Nutrients
2026
Inflammopharmacology
2025
26 उद्धरण
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives.
Review
Autoimmunity reviews
2025
10 उद्धरण
Molecular neurobiology
2025
6 उद्धरण
Modulating inflammation and oxidative stress in rheumatoid arthritis: a systematic review of nutraceutical interventions.
Systematic Review
Inflammopharmacology
2025
1 उद्धरण
Nutrients
2025
Critical reviews in …
2024
25 उद्धरण
Autoimmunity reviews
2024
12 उद्धरण
The Interconnection Between Systemic Lupus Erythematosus and Diet: Unmet Needs, Available Evidence, and Guidance-A Patient-Driven, Multistep-Approach Study.
Systematic Review
Nutrients
2024
2 उद्धरण
European review for …
2023
67 उद्धरण
Nutrients
2022
29 उद्धरण
BMJ (Clinical research …
2022
9 उद्धरण
Journal of medicinal …
2022
8 उद्धरण
Nederlands tijdschrift voor …
2022
1 उद्धरण
Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review.
Systematic Review
Nutritional neuroscience
2021
82 उद्धरण
Clinical science (London, …
2021
35 उद्धरण
Microbiology and immunology
2020
8 उद्धरण
Current rheumatology reviews
2019
40 उद्धरण
FEBS open bio
2016
1 उद्धरण
Environmental health perspectives
2015
72 उद्धरण
Medical hypotheses
2014
36 उद्धरण
Current diabetes reports
2010
33 उद्धरण
Journal of the …
2010
11 उद्धरण
Inhibition of osteoporosis in autoimmune disease prone MRL/Mpj-Fas(lpr) mice by N-3 fatty acids.
Other
Journal of the …
2005
64 उद्धरण
Current opinion in …
2005
26 उद्धरण
Current atherosclerosis reports
2004
464 उद्धरण
Journal of the …
2002
2016 उद्धरण
Age
1998
4 उद्धरण
Biochemical Society transactions
1995
15 उद्धरण
Journal of immunology …
1994
119 उद्धरण
World review of …
1994
8 उद्धरण
The American journal …
1991
2278 उद्धरण
Rheumatic diseases clinics …
1991
19 उद्धरण
Proceedings of the …
1990
49 उद्धरण
The American journal …
1987
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
सामान्य रूप से उपयोग की जाने वाली खुराकें
- general:
- 250-500 mg combined EPA/DHA/day
- antiinflammatory:
- 1,000-3,000 mg combined EPA/DHA/day
अधिकतम सीमा: 3,000 mg/day EPA+DHA (FDA-recognized as safe)
अनुसंधान में अध्ययन की गई खुराकें
| खुराक | अवधि | प्रभाव | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Positive | 1 |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Neutral | -- |
सेवन का सर्वोत्तम समय: With meals
Safety & Side Effects
रिपोर्ट किए गए दुष्प्रभाव
- ⚠ Fishy aftertaste and burping
- ⚠ Gastrointestinal discomfort (nausea, diarrhea)
- ⚠ Increased bleeding risk at high doses
- ⚠ Potential LDL cholesterol increase at very high doses
ज्ञात अंतःक्रियाएँ
- ● Anticoagulants and antiplatelet drugs (may increase bleeding risk)
- ● Blood pressure medications (additive blood pressure lowering)
- ● Orlistat (may reduce omega-3 absorption)
- ● Cyclosporine (may modify immunosuppressive effects)
सहनीय अधिकतम सेवन: 3,000 mg/day EPA+DHA (FDA-recognized as safe)
कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।
Frequently Asked Questions
Does Omega-3 Fatty Acids (EPA/DHA) help with Autoimmune Conditions?
Based on 10 studies with 25,000 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids (EPA/DHA) may support Autoimmune Conditions management. Our evidence grade is B (Good Evidence).
How much Omega-3 Fatty Acids (EPA/DHA) should I take for Autoimmune Conditions?
Studies have used various dosages. A commonly studied range is 250-500 mg combined EPA/DHA/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (EPA/DHA)?
Reported side effects may include Fishy aftertaste and burping, Gastrointestinal discomfort (nausea, diarrhea), Increased bleeding risk at high doses, Potential LDL cholesterol increase at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (EPA/DHA) and Autoimmune Conditions?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 25,000 total participants. The overall direction of effect is positive.
Related Evidence
इसके लिए अन्य सामग्री Autoimmune Conditions
Omega-3 Fatty Acids (EPA/DHA) अन्य स्वास्थ्य स्थितियों के लिए
References
- [1] Sin-Ting Tiffany Lai et al.. Case Rep Endocrinol. 2026. GPIHBP1 Autoantibody-Related Hypertriglyceridemia in a 12-Year-Old Girl With Systemic Lupus Erythematosus. doi:10.1155/crie/6673352 PubMed
- [2] Elena Deseatnicova et al.. Nutrients. 2026. Impact of Nutritional Diet Therapy on Rheumatoid Arthritis Disease Activity. doi:10.3390/nu18030517 PubMed
- [3] Ada Radu et al.. Inflammopharmacology. 2025. Naturally derived bioactive compounds as precision modulators of immune and inflammatory mechanisms in psoriatic conditions. doi:10.1007/s10787-024-01602-z PubMed
- [4] Marta Vomero et al.. Autoimmun Rev. 2025. Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives. doi:10.1016/j.autrev.2025.103896 PubMed
- [5] Ashwani et al.. Mol Neurobiol. 2025. Epigenetic and Mitochondrial Metabolic Dysfunction in Multiple Sclerosis: A Review of Herbal Drug Approaches and Current Clinical Trials. doi:10.1007/s12035-025-04868-8 PubMed
- [6] Camila Leiva-Castro et al.. Inflammopharmacology. 2025. Modulating inflammation and oxidative stress in rheumatoid arthritis: a systematic review of nutraceutical interventions. doi:10.1007/s10787-025-01976-8 PubMed
- [7] Maria Polyzou et al.. Nutrients. 2025. The Role of Nutrition in the Development, Management, and Prevention of Rheumatoid Arthritis: A Comprehensive Review. doi:10.3390/nu17243826 PubMed
- [8] Konstantinos Gkiouras et al.. Crit Rev Food Sci Nutr. 2024. Efficacy of n-3 fatty acid supplementation on rheumatoid arthritis' disease activity indicators: a systematic review and meta-analysis of randomized placebo-controlled … doi:10.1080/10408398.2022.2104210 PubMed
- [9] Kimsor Hong et al.. Autoimmun Rev. 2024. Association between Omega-3 fatty acids and autoimmune disease: Evidence from the umbrella review and Mendelian randomization analysis. doi:10.1016/j.autrev.2024.103651 PubMed
- [10] Savino Sciascia et al.. Nutrients. 2024. The Interconnection Between Systemic Lupus Erythematosus and Diet: Unmet Needs, Available Evidence, and Guidance-A Patient-Driven, Multistep-Approach Study. doi:10.3390/nu16234132 PubMed
- [11] R Poggioli et al.. Eur Rev Med Pharmacol Sci. 2023. Modulation of inflammation and immunity by omega-3 fatty acids: a possible role for prevention and to halt disease progression in … doi:10.26355/eurrev_202308_33310 PubMed
- [12] Yanbin Dong et al.. Nutrients. 2022. Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL … doi:10.3390/nu14245307 PubMed
- [13] Karen H Costenbader. BMJ. 2022. Vitamin D and fish oil supplements and risk of autoimmune disease. doi:10.1136/bmj.o243 PubMed
- [14] Verônica Assalin Zorgetto-Pinheiro et al.. J Med Food. 2022. Omega-3 Fatty Acids and Balanced Gut Microbiota on Chronic Inflammatory Diseases: A Close Look at Ulcerative Colitis and Rheumatoid Arthritis … doi:10.1089/jmf.2021.0012 PubMed
- [15] E Lubberts. Ned Tijdschr Geneeskd. 2022. [Vitamin D like one of few prevention possibilities for autoimmune diseases?]. PubMed
- [16] Welayah Ali AlAmmar et al.. Nutr Neurosci. 2021. Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review. doi:10.1080/1028415X.2019.1659560 PubMed
- [17] Mariana Rodrigues Davanso et al.. Clin Sci (Lond). 2021. Macrophage inflammatory state in Type 1 diabetes: triggered by NLRP3/iNOS pathway and attenuated by docosahexaenoic acid. doi:10.1042/CS20201348 PubMed
- [18] Liu Ouyang et al.. Microbiol Immunol. 2020. Therapeutic effect of omega-3 fatty acids on T cell-mediated autoimmune diseases. doi:10.1111/1348-0421.12800 PubMed
- [19] Leila Chehade et al.. Curr Rheumatol Rev. 2019. Lifestyle Modification in Rheumatoid Arthritis: Dietary and Physical Activity Recommendations Based on Evidence. doi:10.2174/1573397115666190121135940 PubMed
- [20] Mohd Hanif Zulfakar et al.. FEBS Open Bio. 2016. In vivo response of GsdmA3(Dfl)/+ mice to topically applied fish oil - effects on cellular markers and macrophages. doi:10.1002/2211-5463.12095 PubMed
- [21] Emily C Somers et al.. Environ Health Perspect. 2015. Mercury Exposure and Antinuclear Antibodies among Females of Reproductive Age in the United States: NHANES. doi:10.1289/ehp.1408751 PubMed
- [22] Alan D Strickland. Med Hypotheses. 2014. Prevention of cerebral palsy, autism spectrum disorder, and attention deficit-hyperactivity disorder. doi:10.1016/j.mehy.2014.02.003 PubMed
- [23] Jill M Norris. Curr Diab Rep. 2010. Infant and childhood diet and type 1 diabetes risk: recent advances and prospects. doi:10.1007/s11892-010-0131-5 PubMed
- [24] Linda A Linday. J Am Coll Nutr. 2010. Cod liver oil, young children, and upper respiratory tract infections. doi:10.1080/07315724.2010.10719894 PubMed
- [25] Arunabh Bhattacharya et al.. J Am Coll Nutr. 2005. Inhibition of osteoporosis in autoimmune disease prone MRL/Mpj-Fas(lpr) mice by N-3 fatty acids. doi:10.1080/07315724.2005.10719466 PubMed
- [26] Christopher A Jolly. Curr Opin Clin Nutr Metab Care. 2005. Diet manipulation and prevention of aging, cancer and autoimmune disease. doi:10.1097/01.mco.0000172577.56396.7a PubMed
- [27] Trevor A Mori et al.. Curr Atheroscler Rep. 2004. Omega-3 fatty acids and inflammation. doi:10.1007/s11883-004-0087-5 PubMed
- [28] Artemis P Simopoulos. J Am Coll Nutr. 2002. Omega-3 fatty acids in inflammation and autoimmune diseases. doi:10.1080/07315724.2002.10719248 PubMed
- [29] D A Troyer et al.. Age (Omaha). 1998. Effects of calorie restriction and ω-3 dietary fat on aging in short-and long-lived rodents. doi:10.1007/s11357-998-0026-4 PubMed
- [30] D R Robinson et al.. Biochem Soc Trans. 1995. Suppression of autoimmune disease by omega-3 fatty acids. doi:10.1042/bst0230287 PubMed
- [31] G Fernandes et al.. J Immunol. 1994. Increased TGF-beta and decreased oncogene expression by omega-3 fatty acids in the spleen delays onset of autoimmune disease in B/W … PubMed
- [32] D R Robinson et al.. World Rev Nutr Diet. 1994. Alleviation of autoimmune disease by omega 3 fatty acids. doi:10.1159/000424001 PubMed
- [33] A P Simopoulos. Am J Clin Nutr. 1991. Omega-3 fatty acids in health and disease and in growth and development. doi:10.1093/ajcn/54.3.438 PubMed
- [34] D R Robinson. Rheum Dis Clin North Am. 1991. Alleviation of autoimmune disease by dietary lipids containing omega-3 fatty acids. PubMed
- [35] G Fernandes et al.. Proc Soc Exp Biol Med. 1990. Modulation of gene expression in autoimmune disease and aging by food restriction and dietary lipids. doi:10.3181/00379727-193-42983 PubMed
- [36] N J Alexander et al.. Am J Pathol. 1987. The type of dietary fat affects the severity of autoimmune disease in NZB/NZW mice. PubMed
FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।